Survival Benefit of SIRT in mCRC UncertainSurvival Benefit of SIRT in mCRC Uncertain
Dr David Kerr looks at a study of selective internal radiation therapy in hepatic metastatic colorectal cancer, but says the lack of survival data puts the clinical utility of SIRT in question. Medscape Oncology
Source: Medscape Radiology Headlines - Category: Radiology Tags: Hematology-Oncology Commentary Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | Colorectal Cancer | Hematology | Radiation Therapy | Radiology | Study